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AT A GLANCE
Population: 11,331,300
Per capita income: $1,530
Life expectancy at birth: W 66/M 63 yrs
TOP 10 CAUSES OF DEATH
1. Lower Respiratory Infections 
2. HIV
3. Diarrheal Diseases
4. Congenital Birth Defects
5. Cancer
6. Preterm Birth Complications
7. Encephalopathy
8. Neonatal Sepsis
9. Protein Energy Malnutrition
10. Road Injuries
CDC STAFF
9  U.S. Assignees   
38  Locally Employed
HIV/AIDS and Tuberculosis (TB)
CDC Rwanda’s HIV work includes building country capacity in public health 
workforce development, epidemiology, surveillance, health information 
systems, and program monitoring and evaluation. A specific example of health 
information systems work includes the innovative use of cell phone and Internet 
technology to develop a national HIV reporting system and to contributions 
to the national e-health strategy through its support for health management 
information systems.
CDC Rwanda supports developing in-country laboratory workforce capacity, 
progressing toward laboratory accreditation at 10 laboratories, improving 
laboratory infrastructure and information systems, and building capacity at 
individual facilities to deliver high-quality clinical lab services. CDC has also 
worked with the MOH to increase the capacity of its reference laboratory through 
enhanced laboratory diagnostics and through deploying national quality 
management systems. 
People living with HIV are up to 30 times more likely to develop active TB than 
those who are not. CDC Rwanda’s key HIV and TB activities include improving 
and expanding HIV counseling and testing services, TB/HIV integrated service 
delivery, and blood safety services. This work has led to higher TB treatment 
success rates and a stronger, more sustainable TB program.Source: Population Reference Bureau: Rwanda, 2015
Source: GBD Compare: Rwanda, 2015
The Centers for Disease Control and Prevention (CDC) office in Rwanda was established in 2002 with support from the  
U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and CDC’s Division of HIV/AIDS and TB. In 2006 the President’s 
Malaria Initiative (PMI) and influenza programs were added. New projects on noncommunicable diseases are being 
initiated. CDC Rwanda staff specializes in epidemiology, laboratory services, HIV prevention, care and treatment, 
health policy, surveillance and informatics, program management, and monitoring and evaluation. CDC Rwanda staff is 
colocated in the U.S. Embassy and Rwandan Ministry of Health (MOH).
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Malaria
Under the PMI, CDC assigned a resident advisor to Rwanda as a part of an 
interagency team with USAID to support the MOH in implementing malaria 
prevention and control interventions. These include providing long-lasting 
insecticide mosquito nets and indoor residual spraying, preventing malaria 
in pregnancy, improving diagnostics and case management, surveillance, 
and monitoring and evaluation of malaria-related activities. An example 
of CDC technical support is its collaboration with a three-year bed net 
durability study to evaluate how long bed nets remain effective in the field 
and when they should be replaced. Results indicate that over 50% of bed nets 
become ineffective between 18 and 24 months due to holes, but insecticide 
concentration remains relatively stable and effective. CDC has strengthened 
monitoring capacity within the National Malaria Control Program, ensuring 
timely and accurate collection of insecticide resistance data. CDC has also 
supported Rwanda’s transition to a new health management information 
system in health facilities and a community information system to help track 
community health worker activities.
Influenza
Influenza activities are implemented through a CDC cooperative agreement 
with the Rwanda Biomedical Center (RBC) Center for Treatment and 
Research within the Rwanda MOH. CDC supports RBC in preparedness and 
communication, surveillance and disease detection, and response and 
containment to improve Rwanda’s capacity to identify and manage outbreaks 
of avian and pandemic influenza. The cooperative agreement, ‘Preparedness 
and Response to Avian and Pandemic Influenza in Rwanda,’ was formed to 
build capacity to strengthen preparedness and communication for avian and 
pandemic influenza, to initiate human influenza surveillance, and to develop a 
rapid response team at national and subnational levels.
Health Systems Strengthening
CDC’s Field Epidemiology and Laboratory Training Program (FELTP) works with 
MOHs worldwide to strengthen national and local public health systems and 
to address the severe shortage of skilled epidemiologists. By detecting disease 
outbreaks and improving disease monitoring systems, FELTP residents provide 
science and data information to public health leaders to use in public health 
policy and programming. FELTPs are two-year, in-service training programs. The 
students, typically MOH employees, spend 25% of their time in the classroom 
and 75% of time conducting mentored field work. In addition, CDC supports 
the FELTP through its cooperative agreements with the RBC and the School 
of Public Health. FELTP residents have performed more than 30 outbreak 
investigations, 15 surveillance evaluations, and 15 operational researches on 
various topics including anemia in children, injuries, avian influenza, HIV/AIDS, 
malaria, TB, and bacterial antimicrobial resistance since the inception of the 
program. Additionally, residents trained over 300 health workers in outbreak 
investigation and response, public health surveillance, and data management 
to improve disease detection and response.
Immigrant, Refugee, and Migrant Health
CDC conducted a rapid health assessment of Congolese refugees in Rwanda 
that included screening for common infectious diseases and chronic conditions. 
The Congolese will be a large resettlement population in the United States, with 
up to 50,000 arriving in the next four years. The screening information will help 
U.S. state and local health departments prepare for their arrival, and help CDC 
and its partners improve the refugees’ health while waiting for resettlement.
IMPACT IN RWANDA
On July 1st, 2016, the government of Rwanda 
(GOR) adopted the new WHO-recommended 
‘Treat All’ strategy, becoming one of the first 
African countries to implement it.  As a result,  
by December 2016, Rwanda had achieved one 
of the highest national antiretroviral treatment 
(ART) coverage rates in sub-Saharan Africa, 
reaching an estimated 80% of those eligible for 
ART. 
CDC supports 52% of all Rwandan adults and 
children receiving ART in Rwanda, through 
PEPFAR.  As of December 2016, CDC Rwanda was 
supporting ART for 90,085 of the 169,286 people 
living with HIV in Rwanda. 
TB treatment success rates in Rwanda increased 
from 58% in 2003 to 90% by mid-2016. 
In 2016 all health facilities that offered TB 
services also provided directly observed TB 
treatment.
In 2016 Rwanda’s National Center for Blood 
Transfusion (NCBT) qualified for the highest 
award in international standards accreditation 
(Level 3) from the African Society for Blood 
Transfusion, the second African country after 
Namibia to receive this honor. 
For more country information 
www.cdc.gov/globalhealth/countries/rwanda
